AC
AGN

Apex Capital’s Allergan plc AGN Stock Holding History

Apex Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-98,600
Closed -$29.9M – 55
2015
Q2 		$29.9M Sell
98,600
-46,900
-32% -$14M 2.59% 14
2015
Q1 		$43.3M Sell
145,500
-51,100
-26% -$14.6M 3.11% 8
2014
Q4 		$50.6M Buy
196,600
+96,600
+97% +$24.1M 3.54% 6
2014
Q3 		$24.1M Sell
100,000
-88,100
-47% -$19.7M 1.71% 23
2014
Q2 		$42M Sell
188,100
-10,000
-5% -$2.07M 2.62% 10
2014
Q1 		$40.8M Buy
+198,100
New +$39.2M 2.86% 9

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Apex Capital's AGN Position: Q4 2015 in Review

Apex Capital reduced its Allergan plc (AGN) stake by 55% in Q4 2015, selling an estimated $37M and leaving 100,750 shares worth $31.5M. The position accounts for 3.36% of the portfolio, ranked #9.

Apex Capital first reported a position in AGN in Q2 2013 and has held it in 11 quarters since. The position peaked at $72M in Q1 2014. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Apex Capital held 100,750 shares of Allergan plc worth $31.5M as of Q4 2015.
  • Apex Capital sold 124,250 Allergan plc shares in Q4 2015, an estimated $37M.
  • Allergan plc made up 3.36% of Apex Capital's portfolio in Q4 2015, its #9 holding.
  • Apex Capital first reported a position in Allergan plc in Q2 2013 and has held it in 11 quarters since.
  • Apex Capital's Allergan plc position peaked at $72M in Q1 2014.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Apex Capital's 13F filing for Q4 2015, filed 16 Feb 2016.